CBC isn't a household name the way CBD is, but it's been in hemp this whole time. Cannabichromene (CBC) and cannabidiol (CBD) are both non-psychoactive cannabinoids that occur naturally in the hemp plant. If you've ever used a full-spectrum hemp product, you've had both in your system at once. What's different is how they work in the body and how much research has been done on each.
This comparison covers what the current research says about CBC and CBD, how their receptor targets differ, and why the full-spectrum CBD hemp flower we grow on our USDA Organic farm in Wilmore, Kentucky naturally preserves both cannabinoids in every harvest.
What Is CBC (Cannabichromene)?
CBC was first isolated and identified in 1966. It's the third most abundant cannabinoid in most hemp strains, after CBD and CBG. In fresh hemp, it forms from cannabichromenic acid (CBCA), which converts to CBC when exposed to heat or UV light during drying and curing.
Like CBD, CBC doesn't strongly bind to CB1 receptors in the brain. That's what "non-psychoactive" means in this context: the cannabinoid doesn't trigger the intoxicating response that THC does. CBC has a different mechanism. It interacts primarily with TRPA1 and TRPV1 receptors, which are involved in how the body processes sensory input, including pain and temperature signals.
Because CBC concentrations in hemp are relatively low compared to CBD, you won't find many CBC-isolate products on the market. Most people get their CBC through full-spectrum hemp products, where the complete cannabinoid and terpene profile is preserved. That's different from a CBD isolate, which strips out everything except cannabidiol. The full-spectrum approach keeps CBC, CBG, CBN, terpenes, and the trace cannabinoids present in the original plant.
Our hemp COA results break down the full cannabinoid panel, including CBC, for every batch we ship. The exact amounts depend on strain, harvest conditions, and how long the flower was cured. It's not a mystery number hidden in fine print. It's on the lab report.
What Is CBD (Cannabidiol)?
CBD is the most extensively researched non-psychoactive cannabinoid. It's the dominant non-intoxicating compound in hemp by weight, which is a significant reason why hemp (cannabis plants at or below 0.3% Delta-9 THC on a dry weight basis) is a legal agricultural crop under the 2018 Farm Bill.
CBD doesn't bind directly to CB1 or CB2 receptors the way THC does. Instead, it modulates the endocannabinoid system indirectly, through pathways that researchers are still mapping. It also interacts with serotonin receptors and other targets outside the ECS, which may partly explain the breadth of effects people report.
Consumer availability for CBD is wide. Hemp flower, oils, tinctures, gummies, capsules, topicals, roll-ons: the product form options reflect how much market development has happened around this single cannabinoid. That development was driven partly by the research base. There are hundreds of CBD studies ranging from animal trials to human clinical research, including an FDA-approved pharmaceutical (Epidiolex) for specific seizure disorders in children. That approval doesn't extend to over-the-counter hemp products, but it demonstrates how seriously CBD has been studied compared to other cannabinoids.
CBC vs CBD: How They Differ
CBC and CBD are structurally related cannabinoids. Both share the base 21-carbon cannabinoid structure, but they diverge significantly in receptor affinity, research depth, and how you're likely to encounter them in products.
Receptor targets: CBD works primarily by modulating the endocannabinoid system indirectly. CBC targets TRPA1 and TRPV1 receptors directly. Both are non-psychoactive, but through different physiological pathways. That distinction matters if you care about which mechanism you're working with, not just whether a product is "non-psychoactive."
Research depth: CBD has decades of research behind it: animal studies, human clinical trials, published meta-analyses, and an FDA-approved pharmaceutical. CBC's research base is smaller and more recent. Most CBC studies are preclinical (cell studies and animal models), which means the findings are preliminary. They're interesting, but they haven't been confirmed in large human trials the way some CBD research has.
Product availability: CBD dominates the hemp product market. You can buy CBD isolate, broad-spectrum CBD (THC removed), or full-spectrum hemp (full cannabinoid profile). CBC doesn't have its own isolate product category. If you want CBC, full-spectrum hemp is the reliable route.
Where they overlap: The most important overlap is that both are non-psychoactive, both are federally legal under the 2018 Farm Bill when derived from hemp, and both are naturally present in full-spectrum hemp products. A full-spectrum tincture from our Kentucky farm contains CBC alongside CBD, CBG, and the rest of the plant's cannabinoid profile. Not because we added it, but because we preserved it.
Potential Benefits of CBC
The CBC research is early but worth understanding. These findings come from preclinical studies (animal models and cell research) and should be read as promising preliminary evidence, not confirmed clinical outcomes.
Anti-inflammatory support: Multiple preclinical studies have looked at CBC and inflammation. One early study found CBC interacted with specific inflammatory pathways differently from CBD. Another examined how CBC combined with other cannabinoids affected inflammation markers in animal models. The mechanism is different from CBD's and operates through the TRPA1 pathway rather than the ECS.
Neurogenesis support: A 2013 study published in Neurochemistry International found that CBC positively affected the viability and differentiation of neural stem progenitor cells in mice. This is early research, not a clinical recommendation, but neurogenesis is an active research area and the CBC finding stood out because it worked independently from CB1 receptor signaling.
Mood regulation: One study examining full-spectrum hemp extract found that CBC contributed to what the researchers described as mood-elevating effects. The research used the complete cannabinoid profile rather than CBC in isolation, which supports the entourage-effect framing: CBC's contribution may be most meaningful as part of the full-spectrum mix, not as a standalone compound.
Part of the entourage effect: The strongest argument for CBC isn't its isolated mechanism. It's its role in full-spectrum hemp. The entourage effect hypothesis suggests that cannabinoids, terpenes, and plant compounds work better together than in isolation. CBC's presence alongside CBD and the other minor cannabinoids contributes to that complete profile. Whether that contribution is large or small varies by study and by individual.
For a related comparison, our breakdown of CBG vs CBD covers another minor cannabinoid that's naturally present in full-spectrum hemp with its own distinct receptor profile and research history.
Potential Benefits of CBD
The CBD research base is considerably larger than CBC's. That doesn't mean CBD is more effective. They work on different targets and comparing them directly isn't straightforward. It means there's more data to draw on when describing what CBD does in the body.
Relaxation and calm: Consumer-reported benefits consistently cite relaxation as the primary reason for CBD use. Multiple studies support an anxiolytic effect in animal models and some human studies, including a frequently cited 2019 study in The Permanente Journal that found CBD helped reduce anxiety scores and improve sleep in a clinical population. In structure-function terms: CBD may promote calm and help maintain a relaxed state.
Sleep support: CBD's effects on sleep have been studied both alone and in combination with other cannabinoids, especially CBN. Research suggests CBD may support sleep onset when anxiety is a contributing factor. For a comparison of how the two stack up for this use, see our post on CBN vs CBD for sleep: CBN has more direct research on sedative properties, while CBD's sleep support appears to work partly through anxiety reduction.
Joint comfort and recovery: Topical and oral CBD has been studied for inflammation-associated discomfort, particularly in the context of arthritis and exercise recovery. CBD's anti-inflammatory properties in preclinical models have translated into active human research. In structure-function terms: CBD helps support comfortable joints and healthy inflammatory response.
Daily wellness: Many people use CBD as a general supplement without targeting a specific condition, similar to how they might use fish oil, vitamin D, or magnesium. The evidence base for this kind of background use is largely consumer-reported, but it's consistent across years of market data and independent surveys. Our full-spectrum hemp flower and tinctures are used this way by a lot of the people who buy from us regularly.
Which Should You Try?
If you're trying to choose between CBC and CBD, you're probably asking the wrong question. Most people don't access CBC except through full-spectrum hemp products, and most full-spectrum hemp products contain both cannabinoids naturally.
The practical choice is full-spectrum hemp or CBD isolate.
Full-spectrum preserves the complete plant profile: CBD, CBC, CBG, CBN, terpenes, trace cannabinoids, and Delta-9 THC at or below the 0.3% Farm Bill threshold. Broad-spectrum removes the THC. Isolate removes everything except CBD. Each format is valid depending on what you're after, but if you want CBC in your hemp routine, full-spectrum is the only reliable way to get it.
If you're currently using a CBD isolate product and want to explore the full cannabinoid picture, switching to full-spectrum hemp flower or our full-spectrum tincture is straightforward. You don't need to find a "CBC product" specifically. The CBC is already there, in the whole plant, the way it naturally occurs.
CBC and CBD on a Kentucky Hemp Farm
Both CBC and CBD form naturally in hemp plants as they grow. On our USDA Organic farm in Wilmore, Kentucky, where we've been growing hemp since 2018, the complete cannabinoid profile develops through the growing season and is preserved through our drying, curing, and extraction process.
The specific CBC percentage in a given strain or harvest varies. Our Hawaiian Haze, Orange Gas, and Mothership flower all have distinct cannabinoid profiles, and CBC levels differ between them. The full cannabinoid panel, including CBC, is always on the third-party COA for every batch we ship. That's the actual lab data, not a marketing estimate.
For full-spectrum options from our farm: the Relieve full-spectrum tincture preserves the whole cannabinoid profile in a 2,500mg CBD / 1,500mg CBG formulation. Our hemp flower is harvested whole and trimmed by hand to keep the trichomes intact. Our THC-free Relieve tincture is the right choice if you need to avoid trace THC: same USDA Organic Kentucky hemp, just with the THC removed in processing, and still third-party lab tested for the complete cannabinoid panel.
The COAs are on our lab results page if you want to look up a specific product or strain. The CBC number is there along with everything else. Real results from a real Kentucky farm.
Frequently Asked Questions
What is the difference between CBC and CBD?
CBC (cannabichromene) and CBD (cannabidiol) are both non-psychoactive cannabinoids found in hemp, but they work on different receptors. CBD primarily modulates the endocannabinoid system indirectly. CBC interacts mainly with TRPA1 and TRPV1 receptors. CBC has a smaller research base and isn't sold in isolate form; most people encounter it through full-spectrum hemp products.
Does CBC get you high?
No. CBC doesn't strongly bind to the CB1 receptors in the brain that produce THC's intoxicating effect. It's non-psychoactive, the same as CBD. Neither cannabinoid will get you high when used in hemp-derived products that are compliant with the 2018 Farm Bill.
What are the benefits of CBC?
CBC research is still early and mostly preclinical. Studies have looked at anti-inflammatory support, neurogenesis (the growth and differentiation of neural stem cells), and mood regulation in full-spectrum hemp extracts. These are preliminary findings from animal and cell studies, not confirmed clinical outcomes. CBC's most well-supported role is as part of the full cannabinoid profile in full-spectrum hemp, contributing to the entourage effect.
Is CBC legal?
Yes, when derived from hemp. CBC is a naturally occurring cannabinoid in hemp plants, which are legal agricultural crops under the 2018 Farm Bill when plants test at or below 0.3% Delta-9 THC on a dry weight basis. Our hemp is USDA Organic certified, licensed in Kentucky, and third-party lab tested to confirm Farm Bill compliance on every batch.
Can you find CBC in hemp flower?
Yes. CBC is naturally present in hemp flower as part of the full cannabinoid profile. It's the third most abundant cannabinoid in most hemp strains, after CBD and CBG. The exact percentage varies by strain and harvest, but it shows up on our third-party COA results for every batch. If you want to know the CBC content in a specific product, pull the COA from our lab results page.
Is full-spectrum CBD better than CBD isolate?
It depends on what you're after. Full-spectrum hemp preserves the complete cannabinoid and terpene profile, including CBC, CBG, CBN, and trace amounts of Delta-9 THC (under 0.3%). The entourage effect hypothesis suggests these compounds work better together than in isolation. CBD isolate contains only cannabidiol and is the right choice if you need to avoid THC entirely or want a pure CBD product. Our full-spectrum and THC-free options are both third-party lab tested from the same USDA Organic Kentucky farm.
